Amino Acid Metabolism Practice Questions

Q: Which molecule contributes the first carbon atom to urea during its synthesis?

CO2. **Explanation:** The synthesis of urea occurs via the **Urea Cycle (Ornithine Cycle)**, primarily in the liver. The process begins in the mitochondria with the formation of **Carbamoyl Phosphate**. This reaction is catalyzed by the rate-limiting enzyme **Carbamoyl Phosphate Synthetase I (CPS-I)**. The substrates for this first step are **Ammonia (NH3)**, **Bicarbonate (HCO3⁻)**, and **ATP**. The bicarbonate ion (derived from dissolved **CO2**) provides the single carbon atom that eventually forms the carbonyl group of the urea molecule ($NH_2-CO-NH_2$). Therefore, CO2 is the fundamental source of the carbon atom in urea. **Analysis of Incorrect Options:** * **Succinyl CoA:** An intermediate of the TCA cycle and heme synthesis; it does not contribute carbon to the urea cycle. * **Malonyl CoA:** A key intermediate in fatty acid synthesis; it plays no role in nitrogen excretion. * **Acetyl CoA:** While it acts as an allosteric activator for the production of **N-acetylglutamate (NAG)**—the essential cofactor for CPS-I—it does not donate carbon atoms directly to the urea molecule. **High-Yield Clinical Pearls for NEET-PG:** * **Nitrogen Sources:** Urea contains two nitrogen atoms. The first comes from **free ammonia**, and the second is donated by **Aspartate**. * **Rate-Limiting Step:** CPS-I is the rate-limiting enzyme and requires **N-acetylglutamate (NAG)** as an obligatory allosteric activator. * **Compartmentalization:** The first two reactions occur in the **mitochondria**, while the remaining three occur in the **cytosol**. * **Hyperammonemia:** Defects in any urea cycle enzyme lead to ammonia toxicity, with **Ornithine Transcarbamoylase (OTC) deficiency** being the most common (X-linked).

Q: Which enzyme is deficient in oculocutaneous albinism type 1?

Tyrosinase. **Explanation:** **Oculocutaneous Albinism (OCA)** is a group of autosomal recessive disorders characterized by a reduction or absence of melanin pigment in the skin, hair, and eyes. 1. **Why Tyrosinase is Correct:** **OCA Type 1 (OCA1)** is caused by mutations in the *TYR* gene, which encodes the enzyme **Tyrosinase**. This enzyme is the rate-limiting step in melanogenesis, responsible for converting **L-Tyrosine to DOPA** and subsequently **DOPA to Dopaquinone**. A complete absence of tyrosinase activity results in OCA1A (snow-white hair and pink skin), while reduced activity results in OCA1B. 2. **Analysis of Incorrect Options:** * **Pink protein (P-protein):** Deficient in **OCA Type 2**. This is the most common form of albinism worldwide. The P-protein is involved in regulating the pH of melanosomes. * **Tyrosinase-related protein 1 (TRP-1):** Deficient in **OCA Type 3** (often seen in African populations, leading to "Rufous" or reddish-brown albinism). * **Membrane-associated transport protein (MATP/SLC45A2):** Deficient in **OCA Type 4**, which is clinically similar to OCA2 and common in Japan. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting enzyme:** Tyrosinase is the key enzyme for melanin synthesis. * **Precursor:** Tyrosine is the amino acid precursor for melanin, catecholamines (Dopamine, Epinephrine), and Thyroid hormones. * **Clinical Feature:** Patients with OCA have a significantly increased risk of **Squamous Cell Carcinoma (SCC)** due to lack of photoprotective melanin. * **Diagnostic Test:** The **Hair Bulb Incubation Test** (Tyrosinase test) was historically used to differentiate between tyrosinase-positive and tyrosinase-negative albinism.

Q: Cystinuria is characterized by an excess of which amino acid in the urine?

Cysteine. **Explanation:** **Cystinuria** is an autosomal recessive disorder caused by a defect in the high-affinity renal transport system responsible for the reabsorption of dibasic amino acids from the proximal convoluted tubule. **Why Cysteine is Correct:** The defect involves the **COAL** transporter (Cysteine, Ornithine, Arginine, and Lysine). When this transporter fails, these four amino acids are not reabsorbed and are excreted in high amounts in the urine. Among these, **Cysteine** is the most clinically significant because it is relatively insoluble at acidic urinary pH. This leads to the precipitation of cysteine crystals and the formation of radiopaque **hexagonal stones** in the urinary tract. **Why Incorrect Options are Wrong:** * **Tyrosine:** Elevated tyrosine in urine (Tyrosinuria) is associated with Tyrosinemia, a defect in the tyrosine degradation pathway, not a renal transport defect. * **Glutamine:** Glutamine is a neutral amino acid. Its transport is typically unaffected in Cystinuria. * **Valine:** Valine is a branched-chain amino acid. Its accumulation in urine is seen in Maple Syrup Urine Disease (MSUD) due to a decarboxylase deficiency, not a transport defect. **High-Yield Clinical Pearls for NEET-PG:** * **Diagnosis:** The **Cyanide-Nitroprusside test** is the screening test of choice (turns purple/magenta in the presence of cysteine). * **Microscopy:** Pathognomonic **hexagonal crystals** in urine sediment. * **Management:** Treatment focuses on high fluid intake, urinary alkalinization (potassium citrate), and chelating agents like **Penicillamine** (which forms a more soluble complex with cysteine). * **Note:** Do not confuse *Cystinuria* (transport defect) with *Cystinosis* (lysosomal storage disorder).

Q: Arginine enters the TCA cycle by forming which substrate?

α-Ketoglutarate. **Explanation:** Arginine is a glucogenic amino acid that enters the TCA cycle via **α-Ketoglutarate**. The metabolic pathway follows a specific sequence: Arginine is first converted to **Ornithine** (releasing urea via the enzyme Arginase). Ornithine then undergoes transamination to form **Glutamate-γ-semialdehyde**, which is oxidized to **Glutamate**. Finally, Glutamate is deaminated or transaminated to form **α-Ketoglutarate**, a key intermediate of the TCA cycle. **Analysis of Options:** * **α-Ketoglutarate (Correct):** This is the common entry point for the "5-carbon family" of amino acids, which includes **Arginine, Histidine, Proline, and Glutamine**, all of which are first converted to Glutamate. * **Fumarate (Incorrect):** While Arginine is part of the Urea cycle where Fumarate is released, Arginine *itself* does not enter the TCA cycle as Fumarate. Phenylalanine and Tyrosine are the primary amino acids that enter via Fumarate. * **Oxaloacetate (Incorrect):** Asparagine and Aspartate are the amino acids that enter the TCA cycle at the level of Oxaloacetate. * **Succinyl CoA (Incorrect):** This is the entry point for Methionine, Valine, Isoleucine, and Threonine (M-V-I-T). **High-Yield Clinical Pearls for NEET-PG:** * **Glucogenic vs. Ketogenic:** Arginine is purely glucogenic. * **Urea Cycle Link:** Arginine is a semi-essential amino acid and a vital intermediate of the Urea cycle; its cleavage by Arginase is the final step that produces Urea. * **Precursor Molecule:** Arginine is the precursor for **Nitric Oxide (NO)**, **Creatine**, and **Polyamines** (Spermine/Spermidine). * **Mnemonic:** To remember amino acids entering via α-Ketoglutarate, use **"ROHQ"** (Arginine, Ornithine, Histidine, Glutamine).

Q: What enzyme deficiency is tested in the Guthrie test?

Phenylalanine hydroxylase. ### Explanation **Correct Answer: A. Phenylalanine hydroxylase** The **Guthrie Test** is a classic semi-quantitative bacterial inhibition assay used for neonatal screening of **Phenylketonuria (PKU)**. PKU is most commonly caused by a deficiency of the enzyme **Phenylalanine hydroxylase (PAH)**, which converts phenylalanine to tyrosine. * **Mechanism:** The test uses *Bacillus subtilis* spores incorporated into an agar medium containing **β-2-thienylalanine**, a metabolic inhibitor that prevents bacterial growth. If the infant's blood (collected via heel prick) contains high levels of phenylalanine (due to PAH deficiency), the phenylalanine overcomes the inhibition, allowing the bacteria to grow. The diameter of the growth zone is proportional to the concentration of phenylalanine in the blood. **Analysis of Incorrect Options:** * **B. Tyrosine transaminase:** Deficiency leads to **Tyrosinemia Type II** (Richner-Hanhart syndrome), characterized by palmoplantar keratosis and corneal ulcers. * **C. p-Hydroxyphenyl pyruvate dioxygenase:** Deficiency leads to **Tyrosinemia Type III**, a very rare condition involving neurological symptoms. * **D. Homogentisate oxidase:** Deficiency causes **Alkaptonuria**, characterized by ochronosis (darkening of tissues) and urine that turns black upon standing. **High-Yield Clinical Pearls for NEET-PG:** * **Timing:** The Guthrie test must be performed **after 48–72 hours of protein feeding** (breast milk/formula) to allow phenylalanine levels to rise; testing too early leads to false negatives. * **Hyperphenylalaninemia:** While 98% of PKU is due to PAH deficiency, 2% is due to a deficiency in **Dihydrobiopterin reductase** or BH4 synthesis (Malignant PKU). * **Dietary Management:** Treatment involves a diet low in phenylalanine and supplementation with **Tyrosine**, which becomes an **essential amino acid** in these patients.

Q: What is the important role of selenocysteine?

Antioxidant mechanism. **Explanation:** **Selenocysteine** is often referred to as the **21st amino acid**. It is unique because it contains selenium instead of the sulfur atom found in cysteine. Its primary physiological role is serving as a critical component of **selenoproteins**, which are essential for cellular redox homeostasis and protection against oxidative stress. **Why Option C is Correct:** The most prominent selenoprotein is **Glutathione Peroxidase (GPx)**. This enzyme plays a vital role in the **antioxidant mechanism** by reducing hydrogen peroxide ($H_2O_2$) and lipid hydroperoxides into water and alcohols, respectively. By doing so, it prevents the formation of harmful free radicals and protects cell membranes from oxidative damage. Other antioxidant selenoproteins include Thioredoxin Reductase. **Why Other Options are Incorrect:** * **Option A:** The hydroxylation of dopamine to norepinephrine is catalyzed by *Dopamine $\beta$-hydroxylase*, which requires **Vitamin C (Ascorbate)** and Copper as cofactors, not selenocysteine. * **Option B:** The oxidation and detoxification of drugs primarily occur in the liver via the **Cytochrome P450 system**, which utilizes heme-iron complexes, not selenocysteine. **High-Yield NEET-PG Pearls:** * **Genetic Coding:** Unlike other amino acids, selenocysteine is encoded by the **UGA stop codon**. This requires a specific mRNA secondary structure called the **SECIS element** (Selenocysteine Insertion Sequence). * **Deiodinases:** Selenocysteine is also a component of **Iodothyronine deiodinases**, which are responsible for converting the prohormone $T_4$ into the active thyroid hormone $T_3$. * **Synthesis:** It is synthesized while attached to its unique tRNA ($tRNA^{SerSec}$), starting from the amino acid Serine.

Q: Consumption of which amino acid reduces the requirement of methionine due to a sparing effect?

Cysteine. **Explanation:** The correct answer is **Cysteine**. This is a classic example of the **"Sparing Effect"** in amino acid metabolism. **1. Why Cysteine is correct:** Methionine is a sulfur-containing **essential amino acid**. One of its primary metabolic roles is to provide the sulfur atom required for the synthesis of Cysteine (a non-essential amino acid). This occurs via the **transsulfuration pathway**, where Methionine is converted to Homocysteine, which then combines with Serine to form Cystathionine and eventually Cysteine. If Cysteine is supplied adequately through the diet, the body does not need to divert Methionine toward Cysteine synthesis. This "spares" Methionine for its other vital functions, such as protein synthesis and acting as a methyl donor (via S-adenosylmethionine). **2. Why other options are incorrect:** * **Homocysteine:** This is an intermediate in the methionine cycle. While it can be remethylated back to Methionine (requiring B12 and Folate), it does not "spare" the requirement; rather, it is a metabolic byproduct. * **Lysine:** This is a purely ketogenic essential amino acid with no metabolic link to the sulfur-containing pathway of Methionine. * **Arginine:** This is a semi-essential amino acid involved in the urea cycle and nitric oxide synthesis, unrelated to Methionine sparing. **Clinical Pearls for NEET-PG:** * **The Phenylalanine-Tyrosine Parallel:** Just as Cysteine spares Methionine, **Tyrosine spares Phenylalanine**. * **Cystathionine β-synthase (CBS) deficiency:** This is the most common cause of **Homocystinuria**. In these patients, Cysteine becomes an essential amino acid because the pathway to synthesize it from Methionine is blocked. * **Key Cofactors:** The transsulfuration pathway (Methionine → Cysteine) specifically requires **Vitamin B6 (Pyridoxine)**.

Q: Hartnup disease is related to which of the following conditions?

Pellagra symptoms. **Explanation:** **Hartnup disease** is an autosomal recessive disorder characterized by a defect in the **SLC6A19 transporter**. This results in the impaired renal and intestinal transport of neutral amino acids, most significantly **Tryptophan**. **Why Pellagra symptoms is the correct answer:** Tryptophan is a vital precursor for the endogenous synthesis of **Niacin (Vitamin B3)**; approximately 60 mg of Tryptophan yields 1 mg of Niacin. In Hartnup disease, the deficiency of Tryptophan leads to a secondary deficiency of Niacin. Consequently, patients present with **Pellagra-like symptoms**, classically described by the "4 Ds": Dermatitis (photosensitive rash), Diarrhea, Dementia, and eventually Death. **Analysis of Incorrect Options:** * **Rickets symptoms:** Caused by Vitamin D deficiency or calcium/phosphate metabolism defects, leading to bone deformities. It is unrelated to amino acid transport. * **Burning foot syndrome:** Specifically associated with **Pantothenic acid (Vitamin B5)** deficiency. * **Angular stomatitis:** A clinical feature of **Riboflavin (Vitamin B2)** deficiency, also seen in B6, B12, or iron deficiency, but not a primary feature of Hartnup disease. **High-Yield Clinical Pearls for NEET-PG:** * **Diagnosis:** Characterized by **neutral aminoaciduria** (detected via chromatography). Proline, hydroxyproline, and arginine levels remain normal (distinguishing it from Fanconi syndrome). * **Clinical Presentation:** Photosensitive "Casal’s necklace" rash and intermittent cerebellar ataxia. * **Management:** High-protein diet and **Nicotinamide** supplementation. * **Blue Diaper Syndrome:** A related condition involving isolated intestinal malabsorption of Tryptophan, leading to bacterial degradation of Tryptophan into indoles (blue urine).

Q: Alkaptonuria is a metabolic disease caused by a defect in or lack of homogentisic acid oxidase, which leads to what?

Darkly pigmented sclera, cornea, and ear. **Explanation:** **Alkaptonuria** is an autosomal recessive disorder caused by a deficiency of the enzyme **homogentisate 1,2-dioxygenase (HGD)**. This enzyme is essential in the catabolic pathway of phenylalanine and tyrosine. 1. **Why Option C is Correct:** The enzyme deficiency leads to the accumulation of **homogentisic acid (HGA)**. When HGA is excreted in urine and exposed to air, it oxidizes to form a brownish-black pigment. Within the body, HGA undergoes oxidation and polymerization to form a melanin-like pigment that binds to connective tissue, a process known as **Ochronosis**. This results in the characteristic dark pigmentation (slate-blue/grey) of the **sclera, cornea, and ear cartilage**. 2. **Why Incorrect Options are Wrong:** * **Option A (Absent patella):** This is a hallmark of **Nail-Patella Syndrome**, a genetic disorder affecting the LMX1B gene. * **Option B (Blue sclera):** This is classically associated with **Osteogenesis Imperfecta** (Type I collagen defect) or Ehlers-Danlos Syndrome, not Alkaptonuria. * **Option D (Absent radii):** This is seen in **TAR Syndrome** (Thrombocytopenia-absent radius) or Fanconi Anemia. **NEET-PG High-Yield Pearls:** * **Triad of Alkaptonuria:** 1. Homogentisic aciduria (urine turns black on standing/alkalinization), 2. Ochronosis (pigmentation), and 3. Ochronotic arthritis (large joint arthritis and intervertebral disc calcification). * **Diagnosis:** Ferric chloride test (turns urine green/blue) or silver nitrate test. * **Management:** Dietary restriction of Phenylalanine and Tyrosine; **Nitisinone** (inhibits 4-hydroxyphenylpyruvate dioxygenase) is used to reduce HGA production.

Q: What is the byproduct of GABA metabolism?

Succinate. The metabolism of GABA (Gamma-Aminobutyric Acid), the primary inhibitory neurotransmitter in the CNS [1], occurs via a pathway known as the **GABA Shunt**. This process is essential for maintaining the balance of neurotransmitters and providing energy to neurons. 1. **Mechanism of GABA Metabolism:** * GABA is first converted into **Succinic Semialdehyde** by the enzyme **GABA-Transaminase (GABA-T)**. * Succinic semialdehyde is then oxidized by **Succinic Semialdehyde Dehydrogenase (SSADH)** to form **Succinate** (Succinic acid). * Succinate enters the **Kreb’s Cycle (TCA cycle)**, where it is utilized for ATP production. This direct link between neurotransmitter degradation and energy metabolism is why Succinate is the definitive byproduct. **Analysis of Incorrect Options:** * **A. Glutamate:** This is the immediate *precursor* of GABA, formed via the decarboxylation of glutamate by the enzyme GAD (Glutamic Acid Decarboxylase) [2]. * **B. Aspartate:** This is an excitatory neurotransmitter but is not a direct byproduct of the GABA metabolic pathway. * **C. Glycine:** This is a separate inhibitory neurotransmitter primarily active in the spinal cord and brainstem [1]; it is not involved in GABA degradation. **High-Yield Clinical Pearls for NEET-PG:** * **Vigabatrin:** A key pharmacological agent that acts as an **irreversible inhibitor of GABA-Transaminase**. By blocking the conversion of GABA to Succinic semialdehyde, it increases GABA levels in the brain, making it effective for infantile spasms and refractory epilepsy. * **Vitamin B6 (Pyridoxine):** GAD requires Vitamin B6 as a cofactor. Deficiency can lead to decreased GABA levels and seizures. * **GABA Shunt:** It bypasses the alpha-ketoglutarate to succinate step of the TCA cycle.

Question 1

Which molecule contributes the first carbon atom to urea during its synthesis?

Accepted Answer

CO2

Answer

Succinyl CoA

Answer

Malonyl CoA

Answer

Acetyl CoA

Question 2

Which enzyme is deficient in oculocutaneous albinism type 1?

Accepted Answer

Tyrosinase

Answer

Pink protein

Answer

Tyrosinase-related protein 1

Answer

Membrane-associated transport protein (MATP)

Question 3

Cystinuria is characterized by an excess of which amino acid in the urine?

Accepted Answer

Cysteine

Answer

Tyrosine

Answer

Glutamine

Answer

Valine

Question 4

Arginine enters the TCA cycle by forming which substrate?

Accepted Answer

α-Ketoglutarate

Answer

Fumarate

Answer

Oxaloacetate

Answer

Succinyl CoA

Question 5

What enzyme deficiency is tested in the Guthrie test?

Accepted Answer

Phenylalanine hydroxylase

Answer

Tyrosine transaminase

Answer

p-Hydroxyphenyl pyruvate dioxygenase

Answer

Homogentisate oxidase

Question 6

What is the important role of selenocysteine?

Accepted Answer

Antioxidant mechanism

Answer

Hydroxylation of dopamine

Answer

Oxidation of drugs

Answer

None of the above

Question 7

Consumption of which amino acid reduces the requirement of methionine due to a sparing effect?

Accepted Answer

Cysteine

Answer

Homocysteine

Answer

Lysine

Answer

Arginine

Question 8

Hartnup disease is related to which of the following conditions?

Accepted Answer

Pellagra symptoms

Answer

Rickets symptoms

Answer

Burning foot syndrome

Answer

Angular stomatitis

Question 9

Alkaptonuria is a metabolic disease caused by a defect in or lack of homogentisic acid oxidase, which leads to what?

Accepted Answer

Darkly pigmented sclera, cornea, and ear

Answer

Absent patella

Answer

Blue sclera

Answer

Absent radii

Question 10

What is the byproduct of GABA metabolism?

Accepted Answer

Succinate

Answer

Glutamate

Answer

Aspartate

Answer

Glycine

Amino Acid Metabolism — MCQs

Amino Acid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?